Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07 We retrospectively assessed the relationship between chemotherapy ...
CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback